Coronavirus Stocks

Most recent stories in Coronavirus Stocks

• 

  TipRanks

  

  Novavax: Street Underestimating Anticipated Strong Q2 and Outlook, Says Analyst

  tipranks.com - Marty Shtrubel

  The long-awaited emergency use authorization (EUA) for Novavax’s (NVAX) Covid-19 vaccine NVX-CoV2373 was finally granted last month, bringing to an …

• 

  TipRanks

  

  Is Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In

  tipranks.com - Marty Shtrubel

  BioNTech’s product by being the first vaccine authorized for use in children under 6yrs old. Interim data from the KidCOVE trial showed that the …

• 

  TipRanks

  

  TipRanks Investment News

  wpengine.com - Marty Shtrubel

  Competition for top dog billing in the Covid-19 vaccine space has basically turned into a two-horse race. So far, Pfizer (PFE)/BioNTech (BNTX) lead …

• 

  TipRanks

  

  Novavax: Rising Cases Could Lead to Faster Uptake of Covid-19 Vaccine

  tipranks.com - Marty Shtrubel

  regions such as the UK, Australia and the EU. This is bad news for everyone, except of course for the makers of Covid-19 vaccines. The UK, Australia …

• 

  TipRanks

  

  TipRanks Investment News

  wpengine.com - Marty Shtrubel

  Rising Covid-19 cases in China have sent Shenzhen and other cities back into lockdown and there have also been newly confirmed cases in other …

• 

  TipRanks

  Novavax: Covid-19 Vaccine Has Good Odds for EUA Approval, Says Analyst

  tipranks.com - Marty Shtrubel

  After several delays and setbacks, Novavax (NVAX) finally filed an EUA request for its Covid-19 vaccine with the FDA at the end of January. Given …